Fighting antibiotic resistance—strategies and (pre) clinical developments to find new antibacterials

S Walesch, J Birkelbach, G Jézéquel, FPJ Haeckl… - EMBO …, 2023 - embopress.org
Antibacterial resistance is one of the greatest threats to human health. The development of
new therapeutics against bacterial pathogens has slowed drastically since the approvals of …

[HTML][HTML] β-Lactamases and β-Lactamase Inhibitors in the 21st Century

CL Tooke, P Hinchliffe, EC Bragginton… - Journal of molecular …, 2019 - Elsevier
The β-lactams retain a central place in the antibacterial armamentarium. In Gram-negative
bacteria, β-lactamase enzymes that hydrolyze the amide bond of the four-membered β …

Antibiotic resistance breakers: current approaches and future directions

M Laws, A Shaaban, KM Rahman - FEMS microbiology reviews, 2019 - academic.oup.com
Infections of antibiotic-resistant pathogens pose an ever-increasing threat to mankind. The
investigation of novel approaches for tackling the antimicrobial resistance crisis must be part …

Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae?

S Marshall, AM Hujer, LJ Rojas… - Antimicrobial agents …, 2017 - journals.asm.org
Based upon knowledge of the hydrolytic profile of major β-lactamases found in Gram-
negative bacteria, we tested the efficacy of the combination of ceftazidime-avibactam (CAZ …

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

TF Durand-Réville, S Guler, J Comita-Prevoir… - Nature …, 2017 - nature.com
Multidrug-resistant (MDR) bacterial infections are a serious threat to public health. Among
the most alarming resistance trends is the rapid rise in the number and diversity of β …

[HTML][HTML] Antibiotic adjuvants–A strategy to unlock bacterial resistance to antibiotics

C González-Bello - Bioorganic & medicinal chemistry letters, 2017 - Elsevier
Resistance to available antibiotics in pathogenic bacteria is currently a global challenge
since the number of strains that are resistant to multiple types of antibiotics has increased …

β-Lactamase inhibitors to restore the efficacy of antibiotics against superbugs

C González-Bello, D Rodríguez, M Pernas… - Journal of medicinal …, 2019 - ACS Publications
Infections caused by resistant bacteria are nowadays too common, and some pathogens
have even become resistant to multiple types of antibiotics, in which case few or even no …

Strategic approaches to overcome resistance against Gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel …

KM Papp-Wallace, NQ Nguyen… - Journal of medicinal …, 2018 - ACS Publications
Limited treatment options exist to combat infections caused by multidrug-resistant (MDR)
Gram-negative bacteria possessing broad-spectrum β-lactamases. The design of novel β …

Pharmaceutical approaches to target antibiotic resistance mechanisms

D Schillaci, V Spanò, B Parrino… - Journal of medicinal …, 2017 - ACS Publications
There is urgent need for new therapeutic strategies to fight the global threat of antibiotic
resistance. The focus of this Perspective is on chemical agents that target the most common …

Carbon dots as drug delivery vehicles for antimicrobial applications: a minireview

ZX Wang, Z Wang, FG Wu - ChemMedChem, 2022 - Wiley Online Library
Carbon dots are small carbon nanoparticles with intrinsic photoluminescence. Because of
the advantages such as good biocompatibility and water dispersity, many researchers have …